Royal Bank of Canada’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98K | Buy |
7,498
+743
| +11% | +$9.71K | ﹤0.01% | 5271 |
|
|
2025
Q1 | $97K | Sell |
6,755
-1,588
| -19% | -$22.8K | ﹤0.01% | 4890 |
|
|
2024
Q4 | $139K | Buy |
8,343
+2,064
| +33% | +$34.4K | ﹤0.01% | 4655 |
|
|
2024
Q3 | $101K | Buy |
6,279
+5,162
| +462% | +$83K | ﹤0.01% | 4885 |
|
|
2024
Q2 | $10K | Buy |
1,117
+501
| +81% | +$4.49K | ﹤0.01% | 5935 |
|
|
2024
Q1 | $7K | Buy |
616
+525
| +577% | +$5.97K | ﹤0.01% | 5867 |
|
|
2023
Q4 | $1K | Buy |
91
+71
| +355% | +$780 | ﹤0.01% | 6357 |
|
|
2023
Q3 | $0 | Sell |
20
-165
| -89% | – | ﹤0.01% | 6611 |
|
|
2023
Q2 | $1K | Buy |
185
+115
| +164% | +$622 | ﹤0.01% | 6516 |
|
|
2023
Q1 | $0 | Sell |
70
-55
| -44% | – | ﹤0.01% | 6687 |
|
|
2022
Q4 | $0 | Buy |
+125
| New | – | ﹤0.01% | 6789 |
|
|
2021
Q4 | – | Sell |
-453
| Closed | -$8K | – | 7111 |
|
|
2021
Q3 | $8K | Buy |
+453
| New | +$8K | ﹤0.01% | 6500 |
|